(VIANEWS) – Amgen (AMGN), Formula Systems (FORTY), Abbott Laboratories (ABT) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio up until now. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. Amgen (AMGN)

68.29% Payout Ratio

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Volume

Today’s last reported volume for Amgen is 3256720, 6.09% above its average volume of 3069670.

As maintained by Morningstar, Inc., the next dividend payment is on Aug 15, 2021, the estimated forward annual dividend rate is 7.04 and the estimated forward annual dividend yield is 3.37%.

Amgen’s sales growth this year is expected to be 2.4% and 4.3% for next year.

Year-on-year quarterly revenue growth grew by 5.2%, now sitting on 25.48B for the twelve trailing months.

Amgen’s sales growth is 5.5% for the ongoing quarter and 4.9% for the next. The company’s growth estimates for the ongoing quarter and the next is negative 2.3% and 7.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.79%.

Volatility

Amgen’s last day, week, and month’s current intraday variation average was 1.81%, 0.88%, and 0.92%, respectively.

Amgen’s highest amplitude of average volatility was 2.31% (day), 1.99% (last week), and 2.09% (last month), respectively.

Amgen’s Stock Yearly Top and Bottom Value

Amgen’s stock is valued at $235.86 at 08:23 EST, way below its 52-week high of $276.69 and way above its 52-week low of $198.64.

Amgen’s Moving Average

Amgen’s value is way above its 50-day moving average of $208.04 and above its 200-day moving average of $230.55.

2. Formula Systems (FORTY)

43.96% Payout Ratio

Formula Systems (1985) Ltd., through its subsidiaries, provides software, proprietary and non-proprietary software, and software product marketing and support services in Israel and internationally.

Volume

Today’s last reported volume for Formula Systems is 1609, 70.93% below its average volume of 5536.

As stated by Morningstar, Inc., the next dividend payment is on Aug 30, 2021, the estimated forward annual dividend rate is 1.44 and the estimated forward annual dividend yield is 1.4%.

Year-on-year quarterly revenue growth grew by 20.3%, now sitting on 2.29B for the twelve trailing months.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.69%.

Volatility

Formula Systems’s last day, week, and month’s current intraday variation average was 1.14%, 1.34%, and 3.08%, respectively.

Formula Systems’s highest amplitude of average volatility was 3.50% (day), 3.59% (last week), and 3.78% (last month), respectively.

Formula Systems’s Stock Yearly Top and Bottom Value

Formula Systems’s stock is valued at $98.61 at 08:23 EST, way below its 52-week high of $142.00 and way above its 52-week low of $80.98.

Formula Systems’s Moving Average

Formula Systems’s value is under its 50-day moving average of $108.81 and under its 200-day moving average of $103.22.

3. Abbott Laboratories (ABT)

42.43% Payout Ratio

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide.

Volume

Today’s last reported volume for Abbott Laboratories is 3480250, 44.56% below its average volume of 6278480.

As stated by Morningstar, Inc., the next dividend payment is on Oct 13, 2021, the estimated forward annual dividend rate is 1.8 and the estimated forward annual dividend yield is 1.39%.

Abbott Laboratories’s sales growth this year is expected to be 15.1% and a negative 1.4% for next year.

Year-on-year quarterly revenue growth grew by 23.4%, now sitting on 42.31B for the twelve trailing months.

Abbott Laboratories’s sales growth is 6.7% for the current quarter and negative 9.3% for the next. The company’s growth estimates for the ongoing quarter and the next is negative 5.1% and negative -30.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.86%.

Volatility

Abbott Laboratories’s last day, week, and month’s current intraday variation average was 1.44%, 1.54%, and 1.99%, respectively.

Abbott Laboratories’s highest amplitude of average volatility was 2.08% (day), 2.14% (last week), and 2.21% (last month), respectively.

Abbott Laboratories’s Stock Yearly Top and Bottom Value

Abbott Laboratories’s stock is valued at $121.20 at 08:23 EST, below its 52-week high of $134.50 and way above its 52-week low of $105.36.

Abbott Laboratories’s Moving Average

Abbott Laboratories’s worth is below its 50-day moving average of $125.22 and higher than its 200-day moving average of $121.01.

Previous days news about Abbott Laboratories (ABT)

  • Here's how much $1000 invested in abbott laboratories 10 years ago would be worth today. According to Benzinga on Monday, 14 March, "Buying $1,000 In ABT: 10 years ago, an investor could have purchased 34.71 shares of Abbott Laboratories at the time with $1,000. ", "If you had invested $1,000 in Abbott Laboratories you would have approximately $4,012.64 today."

LEAVE A REPLY

Please enter your comment!
Please enter your name here